About TLX
Telix Pharmaceuticals Limited (TLX) is a global biopharmaceutical company engaged in the development and commercialization of targeted therapeutic and diagnostic radiopharmaceuticals, along with supporting medical technologies. Headquartered in Melbourne, Australia, Telix maintains strategic international operations across the United States, Brazil, Canada, Europe (Belgium and Switzerland), and Japan.
Find out what a historical investment in Telix Pharmaceuticals Limited would be worth today using our TLX stock calculator.
Market Capitalisation
$5.39B
Price-earnings ratio
-503.81
Dividend yield
-
High today
$16.02
Low today
$15.71
Open price
$15.90
52-week high
$18.22
52-week low
$8.26
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in TLX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in TLX on Stake
- Buy TLX from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
TLX related stocks